• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质细胞衍生因子 1 诱导骨髓间充质干细胞向神经元样细胞分化及其机制的研究

Oncostatin-M-Reactive Pericytes Aggravate Blood-Brain Barrier Dysfunction by Activating JAK/STAT3 Signaling In Vitro.

机构信息

Department of Pharmaceutical Care and Health Sciences, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka 814-0180, Japan.

Department of Pediatrics, Tokyo Medical University, Shinjuku-ku, Tokyo 160-0023, Japan.

出版信息

Neuroscience. 2019 Dec 1;422:12-20. doi: 10.1016/j.neuroscience.2019.10.014. Epub 2019 Nov 6.

DOI:10.1016/j.neuroscience.2019.10.014
PMID:31705893
Abstract

Oncostatin M (OSM) is a cytokine of the interleukin (IL)-6 family members. It induces blood-brain barrier (BBB) dysfunction by activating Janus-activated kinase (JAK) and signal transducer and activator of transcription (STAT) 3 pathways in brain endothelial cells. Brain pericytes located around microvessels are one of the BBB constituents. Pericytes work as a boundary surface between the blood circulation and brain parenchyma, and their functions are altered under pathophysiological conditions, leading to BBB dysregulation. However, it remains unknown whether pericytes are associated with OSM-induced BBB dysfunction. We demonstrated that pericyte exposure to OSM (100 ng/mL) elevated phosphorylation of STAT3, a main OSM signaling pathway, and that pericytes expressed OSM receptors (OSMRs) including OSMRβ and glycoprotein 130. These results suggest that pericytes are able to respond to OSM. To determine the effects of OSM-reactive pericytes on BBB functions, rat brain endothelial cell (RBEC) monolayers were cultured with OSM-treated pericytes. The presence of pericytes exposed to 100 ng/mL of OSM for 48 h aggravated both the elevated permeability to sodium fluorescein and the lowered transendothelial electrical resistance which were induced by OSM in RBECs. This OSM-reactive pericyte-induced aggravation of lowered RBEC barrier function was reversed by ruxolitinib, a JAK inhibitor. These findings suggest that activated JAK/STAT3 signaling in pericytes contributes to OSM-produced BBB breakdown. Thus, OSM-reactive pericytes may have to be considered a characteristic machinery in the formation and progression of BBB breakdown under pathological conditions associated with increased OSM levels.

摘要

肿瘤坏死因子样弱诱导剂(OSM)是白细胞介素(IL)-6 家族成员的细胞因子。它通过激活脑内皮细胞中的 Janus 激活激酶(JAK)和信号转导子和转录激活子(STAT)3 途径来诱导血脑屏障(BBB)功能障碍。位于微血管周围的脑周细胞是 BBB 的组成部分之一。周细胞作为血液循环和脑实质之间的边界表面,其功能在病理生理条件下发生改变,导致 BBB 失调。然而,目前尚不清楚周细胞是否与 OSM 诱导的 BBB 功能障碍有关。我们证明,周细胞暴露于 OSM(100ng/mL)会增加 STAT3 的磷酸化,这是 OSM 的主要信号通路,并且周细胞表达 OSM 受体(OSMRs),包括 OSMRβ和糖蛋白 130。这些结果表明周细胞能够对 OSM 做出反应。为了确定对 OSM 有反应的周细胞对 BBB 功能的影响,用 OSM 处理的周细胞培养大鼠脑内皮细胞(RBEC)单层。在存在暴露于 100ng/mL OSM 48 小时的周细胞的情况下,OSM 在 RBEC 中诱导的对荧光素钠的通透性增加和跨内皮电阻降低加剧。这种 OSM 反应性周细胞诱导的 RBEC 屏障功能降低的加重被 JAK 抑制剂鲁索替尼逆转。这些发现表明,周细胞中激活的 JAK/STAT3 信号通路有助于 OSM 产生的 BBB 破裂。因此,在与 OSM 水平升高相关的病理条件下,激活的 OSM 反应性周细胞可能成为 BBB 破裂形成和进展的特征机制。

相似文献

1
Oncostatin-M-Reactive Pericytes Aggravate Blood-Brain Barrier Dysfunction by Activating JAK/STAT3 Signaling In Vitro.基质细胞衍生因子 1 诱导骨髓间充质干细胞向神经元样细胞分化及其机制的研究
Neuroscience. 2019 Dec 1;422:12-20. doi: 10.1016/j.neuroscience.2019.10.014. Epub 2019 Nov 6.
2
Oncostatin M-induced blood-brain barrier impairment is due to prolonged activation of STAT3 signaling in vitro.体外研究显示,抑瘤素 M 诱导血脑屏障损伤是由于 STAT3 信号的持续激活。
J Cell Biochem. 2018 Nov;119(11):9055-9063. doi: 10.1002/jcb.27162. Epub 2018 Aug 4.
3
Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.白血病抑制因子(LIF)和抑瘤素M(OSM)对人颗粒细胞系COV434中JAK/STAT信号通路的刺激作用
J Reprod Immunol. 2015 Apr;108:48-55. doi: 10.1016/j.jri.2015.03.002. Epub 2015 Mar 16.
4
The inflammatory mediator oncostatin M induces angiopoietin 2 expression in endothelial cells in vitro and in vivo.炎症介质骨桥蛋白 M 在体外和体内诱导内皮细胞表达血管生成素 2。
J Thromb Haemost. 2010 Mar;8(3):596-604. doi: 10.1111/j.1538-7836.2010.03741.x. Epub 2009 Dec 17.
5
The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation.结合位点 III 中人类肿瘤坏死因子样弱诱导剂(OSM)的 AB 环和 D 螺旋对于 OSM 受体的激活是必需的。
J Biol Chem. 2018 May 4;293(18):7017-7029. doi: 10.1074/jbc.RA118.001920. Epub 2018 Mar 6.
6
Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass.小鼠抑瘤素M通过白血病抑制因子受体作用使信号转导和转录激活因子3(STAT3)磷酸化,但不使STAT1磷酸化,该效应可保护骨量。
J Biol Chem. 2016 Oct 7;291(41):21703-21716. doi: 10.1074/jbc.M116.748483. Epub 2016 Aug 18.
7
Oncostatin M receptor, positively regulated by SP1, promotes gastric cancer growth and metastasis upon treatment with Oncostatin M.受 SP1 正向调控的抑瘤素 M 受体促进了抑瘤素 M 治疗后的胃癌生长和转移。
Gastric Cancer. 2019 Sep;22(5):955-966. doi: 10.1007/s10120-019-00934-y. Epub 2019 Feb 18.
8
STAT3 Mediates the Differential Effects of Oncostatin M and TNFα on RA Synovial Fibroblast and Endothelial Cell Function.STAT3 介导了 Oncostatin M 和 TNFα 对 RA 滑膜成纤维细胞和内皮细胞功能的差异作用。
Front Immunol. 2019 Aug 28;10:2056. doi: 10.3389/fimmu.2019.02056. eCollection 2019.
9
Oncostatin M promotes excitotoxicity by inhibiting glutamate uptake in astrocytes: implications in HIV-associated neurotoxicity.抑瘤素M通过抑制星形胶质细胞对谷氨酸的摄取促进兴奋性毒性:对HIV相关神经毒性的影响。
J Neuroinflammation. 2016 Jun 10;13(1):144. doi: 10.1186/s12974-016-0613-8.
10
Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.抑瘤素M对Jak-Stat和MAPK信号通路的激活不足以导致人胶质瘤细胞的生长抑制。
Brain Res Mol Brain Res. 2000 Sep 15;80(2):198-206. doi: 10.1016/s0169-328x(00)00162-5.

引用本文的文献

1
Unlocking therapeutic potential in traumatic brain injury: exploring microenvironmental targets, signaling pathways and translational hurdles.挖掘创伤性脑损伤的治疗潜力:探索微环境靶点、信号通路及转化障碍
Inflammopharmacology. 2025 Sep;33(9):5113-5144. doi: 10.1007/s10787-025-01923-7. Epub 2025 Sep 1.
2
Exercise-mediated IL-6 downstream effects modulate brain pathology-can exercise training protocols influence the downstream effects?运动介导的白细胞介素-6下游效应调节脑病理学——运动训练方案能否影响下游效应?
Front Neurol. 2025 Aug 6;16:1639427. doi: 10.3389/fneur.2025.1639427. eCollection 2025.
3
Experimental and clinical tests of FDA-approved kinase inhibitors for the treatment of neurological disorders (update 2024).
美国食品药品监督管理局(FDA)批准的用于治疗神经疾病的激酶抑制剂的实验和临床测试(2024年更新)
Explor Drug Sci. 2025;3. doi: 10.37349/eds.2025.1008116. Epub 2025 Jul 1.
4
Investigating the Potential Therapeutic Targeting of the JAK-STAT Pathway in Cerebrovascular Diseases: Opportunities and Challenges.研究JAK-STAT通路在脑血管疾病中的潜在治疗靶点:机遇与挑战
Mol Neurobiol. 2025 Mar 18. doi: 10.1007/s12035-025-04834-4.
5
The blood-brain barrier: a help and a hindrance.血脑屏障:既是帮手也是阻碍。
Brain. 2025 Jul 7;148(7):2262-2282. doi: 10.1093/brain/awaf068.
6
Blood-brain barrier permeability increases with the differentiation of glioblastoma cells in vitro.血脑屏障通透性随体外胶质母细胞瘤细胞的分化而增加。
Fluids Barriers CNS. 2024 Nov 1;21(1):89. doi: 10.1186/s12987-024-00590-0.
7
Causal associations between gut microbiota, circulating inflammatory proteins, and epilepsy: a multivariable Mendelian randomization study.肠道微生物群、循环炎症蛋白与癫痫之间的因果关联:多变量孟德尔随机化研究。
Front Immunol. 2024 Sep 9;15:1438645. doi: 10.3389/fimmu.2024.1438645. eCollection 2024.
8
Dynamic development of microglia and macrophages after spinal cord injury.脊髓损伤后小胶质细胞和巨噬细胞的动态发育
Neural Regen Res. 2025 Dec 1;20(12):3606-3619. doi: 10.4103/NRR.NRR-D-24-00063. Epub 2024 Jul 29.
9
Characterization of Proteome Changes in Aged and Collagen VI-Deficient Human Pericyte Cultures.年龄增长和胶原 VI 缺陷人周细胞培养物中蛋白质组变化的特征。
Int J Mol Sci. 2024 Jun 28;25(13):7118. doi: 10.3390/ijms25137118.
10
The Role and Therapeutic Implications of Inflammation in the Pathogenesis of Brain Arteriovenous Malformations.炎症在脑动静脉畸形发病机制中的作用及治疗意义
Biomedicines. 2023 Oct 24;11(11):2876. doi: 10.3390/biomedicines11112876.